Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: J Allergy Clin Immunol. 2010 Jun 12;126(1):127–32.e7. doi: 10.1016/j.jaci.2010.04.026

FIG 2.

FIG 2

Decreased NEMO protein and mRNA levels in the patient. Western blots from PBMC lysates from control, index patient, affected brother, and unaffected mother (A) and EBV B-cell lysates (B). C, Scanning densitometry of NEMO protein levels for each EBV B cell line, normalized to actin. Controls arbitrarily set to 1. D, qPCR analysis of NEMO mRNA levels, normalized to GAPDH, in EBV B-cell lines from index patient, brother, and 8 controls. Bar represents the mean. Dashed lines span the 95% CI.